home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

DNA Vaccine Banishes TB

  February, 8 2005 9:40
your information resource in human molecular genetics
A new gene therapy approach could help completely eliminate the infection that causes one of the world's biggest killers – tuberculosis (TB).

Chemotherapy alone cannot kill all the bacteria that cause TB: remaining bacteria can reactivate decades after treatment. Gene Therapy this week reports that a DNA vaccination administered in conjunction with chemotherapy completely blocks reactivation of the bacteria and significantly prevents a secondary infection.

Korean researchers in Youngchul Sung's team have shown that a DNA vaccine can work in animals already exposed to the bacteria, to prevent reinfection, where chemotherapy has been the only option. This new therapy could prove beneficial to patients undergoing TB chemotherapy to prevent either reactivation of the bacteria or reinfection from a secondary source.

Author contact:

Youngchul Sung (Pohang University of Science and Technology, Kyungbuk, Republic of Korea)
Tel: +82 279 2294

Alternative Contact:

Douglas B Lowrie (National Institute for Medical Research, London, UK)
E-mail: dlowrie@nimr.mrc.ac.uk

(C) Gene Therapy press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.